BYRN Byrna Technologies Inc. Insider Trading

Ganz Bryan purchased 1,500 shares of BYRN at $6.56 on 2026-04-15 (total $9,840.00); stock now down 80.1% from 52-week high of $33.56.

Ganz Bryan acquired 1,500 shares of Byrna Technologies at $6.56, increasing his holdings to 382,673 shares. The timing is notable given current market conditions: BYRN has fallen 80.1% from its 52-week high of $33.56 and is down 30.4% over 30 days and 61.8% over 90 days. However, Bryan's prior five trades at this same ticker show a mixed pattern—two of five prior sells were well-timed at the 90-day mark, indicating moderate timing acuity specific to BYRN. Meanwhile, his cross-ticker track record demonstrates stronger recent conviction: 2 prior buys averaged +52.9% at 30 days and +75.4% at 90 days with a 100% win rate. Against this backdrop, the current purchase occurs into a depressed stock price absolute to its range, though the company maintains solid fundamentals with $29,049,000.00 in latest-quarter revenue, a 37.7% annual growth rate, and positive net income of $801,000.00.

CEO Ganz Bryan sells 40,000 BYRN shares at $29.90; stock now -27.0% from 52-week high but +24.9% in 30 days

CEO Ganz Bryan sold 40,000 shares (40.0K shares) at $29.90 on 2025-10-10, reducing his holdings by 12.2% from 328,059 to 288,059 shares. The sale occurred near the peak of a recent rally: the stock is currently at $24.95, down 27.0% from its 52-week high of $34.19, but up 24.9% over the preceding 30 days and up 9.0% over 90 days. At his same ticker (BYRN), Bryan's track record is mixed: his prior two sales (Feb 2025 and Sep 2024) showed returns of -38.0% and -19.2% at 30-day horizons respectively, and 2 of 5 prior BYRN trades were well-timed at 90-day measurement. His cross-ticker record on prior sells shows an average 90-day return of +44.2% with a well-timed rate of 25.00%, suggesting these sales have generally preceded further stock appreciation. The company's fundamentals remain robust: annual revenue growth of +101.1%, a P/E of 35.64, and net income of $2.2M on $28.2M quarterly revenue, though the elevated valuation warrants attention given the recent price recovery.

Director Rooney Emily buys 2,500 shares of BYRN at $20.50; holdings now 37.6K shares amid +101.1% annual revenue growth.

Rooney Emily, a director at Byrna Technologies, purchased 2,500 shares at $20.50 on 2025-04-22, increasing her holdings to 37.6K shares. The company is in a growth phase with annual revenue growth of +101.1% and a latest quarterly revenue of $26.2M with $1.7M net income, supporting a market cap of $504.3M. The current stock price is $22.25, down 34.9% from the 52-week high of $34.19 but up 17.9% over the past 30 days, representing a modest pullback from recent peaks. This insider purchase occurs in the context of substantial top-line expansion and profitability, though the elevated P/E of 34.77 suggests the market is pricing in significant future growth expectations.

COO Brasseur buys 728 shares of BYRN at $20.19; stock up 19.7% in 30 days but -25.9% over 90 days

John Brasseur, Chief Operating Officer, purchased 728 shares at $20.19, representing an 8.7% increase to his holdings of 9,068 shares. The purchase occurs within a volatile trading window: while BYRN is up 19.7% over the past 30 days, it remains -25.9% over 90 days and -36.3% from its 52-week high of $34.19. The company shows strong fundamentals with annual revenue growth of +101.1%, a profitable $1.7M net income in the latest quarter, and a $26.2M quarterly revenue run rate, though its P/E of 34.03 reflects elevated valuation expectations. The insider's purchase at $20.19 sits between the stock's recent momentum gains and its broader downtrend, amid substantial market-cap volatility in a $493.7M company.

Byrna CEO Ganz Bryan sold 50,000 shares at $29.37 on 2025-02-20; stock now at $28.51, down 8.4% in 30 days.

Ganz Bryan, President and CEO of Byrna Technologies, sold 50,000 shares (13.2% reduction from 378,059 holdings) at $29.37, representing a significant single-transaction disposal by a top executive. The stock has declined 8.4% over the 30 days post-sale and currently trades at $28.51, below the sale price. His prior sales at Byrna (September 2024) showed negative 30-day returns ranging from -4.6% to -19.2%, establishing a pattern of sales followed by near-term weakness. The company's fundamentals show strong growth (revenue $20.9M, +101.1% annual growth, positive net income of $1.0M), which contrasts with the recent price momentum: the stock is -16.6% from its 52-week high and down 8.4% over 30 days despite +33.8% growth over 90 days. The insider's cross-ticker sell track record shows 0.00% well-timed rate (meaning prior sales were followed by stock appreciation), but his same-ticker history at Byrn shows mixed timing, with 2 of 5 prior trades well-timed at the 90-day mark.

CMO Pham Luan sold 33.5K shares (63.6% of holdings) at $30.19; stock up 18.9% in 30 days, 79.0% in 90 days post-sale.

Pham Luan, Chief Marketing and Revenue Officer, executed a large reduction in BYRN holdings on 2025-02-12, selling 33,483 shares at $30.19 and retaining only 19,148 shares post-transaction. The timing is notable: the stock has appreciated 18.9% over the past 30 days and 79.0% over the past 90 days following his sale, indicating the insider sold ahead of a significant rally. His cross-ticker track record shows 0 well-timed sells across prior transactions, but at this ticker specifically, his two prior buys in July 2023 both declined within 90 days (average 90-day return −10.0%), establishing a pattern of poor entry timing at BYRN. The current price of $32.80 sits 4.1% below the 52-week high, yet remains substantially above the $30.19 sale price, suggesting the disposal may have left material upside unrealized during a momentum-driven period.

CFO Laurilee Kearnes buys 1,000 BYRN shares at $18.60; holdings rise 40% to 3.5K shares amid 81.5% 90-day rally.

Laurilee Kearnes, Chief Financial Officer of Byrna Technologies, purchased 1,000 shares at $18.60 on 2024-11-15, increasing her holdings by 40.0% from 2,500 to 3,500 shares. The purchase arrived as the stock surged 81.5% over the prior 90 days and trades at $19.06 (within 0.0% of its 52-week high), suggesting the CFO bought into significant momentum rather than a depressed entry point. Fundamentally, the company remains challenged: annual revenue declined 11.2% year-over-year, the full-year net income was negative, and the P/E ratio of 190.60 reflects a highly valued earnings profile. Her cross-ticker track record shows a 0.00% 90-day win rate on prior buys (averaging -4.3% 90-day returns), though her most recent Byrna purchase on 2024-10-10 posted a +24.7% 30-day return, providing limited evidence of market-timing skill at this specific ticker.

CFO Kearnes purchases 2,000 shares of BYRN at $14.04; stock down 26.3% from 52-week high despite +39.2% 90-day rally.

CFO Laurilee Kearnes purchased 2,000 shares at $14.04, increasing her holdings to 2,500 shares from 500 shares (+400.0%). The transaction occurs within the context of significant price volatility: BYRN is -26.3% from its 52-week high ($18.95) but +39.2% over 90 days, suggesting the stock has recovered substantially from depressed levels. Kearnes' cross-ticker track record shows mixed results: 1 prior buy with avg 90d return of -4.3% and 0.00% win rate, indicating her prior market-timing decisions have not generated positive 90-day outcomes. Company fundamentals remain stressed—BYRN reported a full-year net loss, negative annual revenue growth (-11.2%), and a very high P/E of 139.60, raising questions about valuation and earnings sustainability.

CEO Bryan Ganz sells 37,522 shares at blended $17.89, raising $671,416.13, as BYRN hits 52-week highs after 82.6% 90-day surge

Ganz executed 3 separate sales totaling 37,522 shares for $671,416.13 across a 4-day window (Sept 20–24, 2024) at prices ranging from $17.40 to $17.98, reducing his holdings by 8.6%. The filing occurs as BYRN trades at $18.30, matching its 52-week high after a 82.6% surge over 90 days and +65.3% over 30 days—an extreme run-up from the $2.24 52-week low. However, the company reported full-year net income was negative and current-quarter net income of $2.1M sits against revenue decline of 11.2% year-over-year, creating a disconnect between valuation momentum and underlying profitability. Ganz's prior two purchases at BYRN in October 2023 both showed strong 90-day gains, suggesting he had previously identified value; the contrast between those conviction-driven buys and this multi-tranche sell during a sharp appreciation warrants investor scrutiny of whether fundamental momentum can sustain recent price action.